Scotiabank Adjusts Price Target on Vertex Pharmaceuticals to $442 From $450, Maintains Sector Perform Rating
Published on 06/05/2025 at 12:19

Published on 06/05/2025 at 12:19
Market Closed -
Other stock markets
|
||
463.27 USD | -1.34% |
Select your edition
All financial news and data tailored to specific country editions